PLUS THERAPEUTICS, INC. Annual Return On Assets in % from 2012 to 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Plus Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2024.
  • Plus Therapeutics, Inc. Return On Assets for the quarter ending December 31, 2024 was -171 %, a 74.5% decline year-over-year.
  • Plus Therapeutics, Inc. annual Return On Assets for 2024 was -171 %, a 74.5% decline from 2023.
  • Plus Therapeutics, Inc. annual Return On Assets for 2023 was -97.7 %, a 11.8% decline from 2022.
  • Plus Therapeutics, Inc. annual Return On Assets for 2022 was -87.4 %, a 40.1% decline from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -171 -72.8 -74.5% Jan 1, 2024 Dec 31, 2024
2023 -97.7 -10.3 -11.8% Jan 1, 2023 Dec 31, 2023
2022 -87.4 -25 -40.1% Jan 1, 2022 Dec 31, 2022
2021 -62.4 -6.17 -11% Jan 1, 2021 Dec 31, 2021
2020 -56.2 -3.4 -6.44% Jan 1, 2020 Dec 31, 2020
2019 -52.8 -1.69 -3.31% Jan 1, 2019 Dec 31, 2019
2018 -51.1 +24.3 +32.2% Jan 1, 2018 Dec 31, 2018
2017 -75.4 -15.5 -25.8% Jan 1, 2017 Dec 31, 2017
2016 -60 -14.2 -30.9% Jan 1, 2016 Dec 31, 2016
2015 -45.8 +54.7 +54.4% Jan 1, 2015 Dec 31, 2015
2014 -101 -30.9 -44.4% Jan 1, 2014 Dec 31, 2014
2013 -69.6 +8.7 +11.1% Jan 1, 2013 Dec 31, 2013
2012 -78.3 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.